v3.26.1
Nature of Operations and Basis of Presentation (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 09, 2026
Jan. 29, 2026
Jun. 30, 2024
Jun. 30, 2026
Dec. 31, 2027
Dec. 31, 2025
Nature of Operations and Basis of Presentation [Line Items]            
Cash and cash equivalents       $ 9,598,916   $ 5,164,875
Current liabilities       2,116,641   1,119,197
Accumulated deficit       $ (45,760,521)   $ (41,517,267)
Incorporated date       Mar. 20, 2015    
Patient mortality period     28 days      
Cumulative risk period       28 days    
Reverse stock split period       12 months    
Bid price       $ 1    
Minimum [Member] | Forecast [Member]            
Nature of Operations and Basis of Presentation [Line Items]            
Expected raise of capital         $ 10,000,000  
Maximum [Member] | Forecast [Member]            
Nature of Operations and Basis of Presentation [Line Items]            
Expected raise of capital         $ 14,000,000  
Common Stock [Member]            
Nature of Operations and Basis of Presentation [Line Items]            
Number of common stock (in Shares) 500,000          
January 2026 Reverse Stock Split [Member] | Common Stock [Member]            
Nature of Operations and Basis of Presentation [Line Items]            
Reverse stock split ratio   1-for-4        
Additional Reverse Stock Split [Member] | Common Stock [Member]            
Nature of Operations and Basis of Presentation [Line Items]            
Reverse stock split ratio 1-for-20